OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports. © 2024 TechCrunch. All rights reserved. For personal use only.

Sam Altman's OpenAI is backing a new AI initiative from a group where John Kerry was a founding member that has voiced support for liberal causes in the past.

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching its nonprofit mandate. Although the lawsuit was withdrawn in June, Musk refiled it in August, further intensifying the conflict.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO slammed the new artificial intelligence (AI) infrastructure project,

President Trump dismissed Elon Musk’s doubts about the $500 billion “Stargate” AI project, citing personal differences. OpenAI CEO Sam Altman defended the project and invited Musk to visit the construction site.

Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam Altman.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.